What is Picard Medical, Inc.?
, through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.
PMI · Verdict
Limited reward · elevated risk
PMI's standout is volatility; cash flow and profitability weigh on the picture.
Based on 88% data coverage
PMI · Verdict
Top decile vs peers
-270% free-cash-flow margin
-480% net margin · 0% ROE
Current ratio 0.28
Rev +3.3% CAGR · earnings +37.3%
Model-based scoring. For information only — not financial advice.
, through its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company is listed on the NYSE MKT in USA, operating in the Healthcare sector, with a market capitalisation of 79.60M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.